8 results
424B3
ITCI
Intra-Cellular Therapies, Inc.
4 Apr 14
Prospectus supplement
12:00am
in the United States from 2007 to 2009. ITI-007 was well tolerated, all AEs were of mild or moderate intensity and all treatment related AEs resolved. Dose
424B1
dq6i q5cjv42l0v
31 Jan 14
Prospectus with pricing info
12:00am
424B3
7xqewo0ol bivge
19 Dec 13
Prospectus supplement
12:00am
8-K/A
tih7o
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next